Uterine fibroids, also known as myomas, are common benign uterine tumors in women of reproductive age. They can cause discomfort, pain, heavy menstrual bleeding, dysmenorrhea, frequent urination, infertility, and low quality of life.
Approximately 70–80% of women will acquire uterine fibroids at some point in their lives.1 Some will develop clinical symptoms influenced by the location, size, and number of fibroids.
Uterine Fibroids are typically found during a standard gynecologic checkup with a pelvic examination. If irregularities are noticed, the physician may order additional tests.
Uterine Fibroids are typically found during a standard gynecologic checkup with a pelvic examination. If irregularities are noticed, the physician may order additional tests.
The MYOBLATE™ electrodes are CE-certified and indicated for the treatment of uterine fibroids. The content herein is solely for informational and educational purposes and should not be construed as medical or health advice. While the MYOBLATE™ Uterine Fibroid RFA Procedure may offer substantial benefits to many patients, it is not universally applicable, and individual outcomes may vary. Please contact your medical professional for specific advice regarding the potential benefits, risks, and suitability of this treatment in your specific case.
This information is not intended as an offer for sale or promotion in jurisdictions where such activities are restricted. The imagery used in this material is for illustrative purposes only, featuring models, and should not be interpreted as an endorsement or representation of typical patient outcomes. For more details about information provided on this Site, please click here.
© 2024 MYOBLATE.
